Skip to content
Filters
Vendor
Collection
Tags
- Adjuvant Aromatase Inhibitor Therapy (1)
- Bone Loss (1)
- Bone Resorption Inhibitor (1)
- Breast Cancer (1)
- Breast Cancer Medication (1)
- Denosumab (1)
- doctor-only (1)
- Men with Osteoporosis (1)
- osteoporosis (1)
- Postmenopausal Women (1)
- prefilled syringe (1)
- prefilled syringes (1)
- Prolia (1)
- Prolia Denosumab (1)
- Prolia Denosumab 60 mg (1)
- Treat Breast Cancer (1)
- Treat Osteoporosis (1)
- Treatment of Bone Loss (1)
Filters
Vendor
Collection
Tags
- Adjuvant Aromatase Inhibitor Therapy (1)
- Bone Loss (1)
- Bone Resorption Inhibitor (1)
- Breast Cancer (1)
- Breast Cancer Medication (1)
- Denosumab (1)
- doctor-only (1)
- Men with Osteoporosis (1)
- osteoporosis (1)
- Postmenopausal Women (1)
- prefilled syringe (1)
- prefilled syringes (1)
- Prolia (1)
- Prolia Denosumab (1)
- Prolia Denosumab 60 mg (1)
- Treat Breast Cancer (1)
- Treat Osteoporosis (1)
- Treatment of Bone Loss (1)
Breast Cancer Medicines for Bone Resorption Inhibitor
-
Sale 34%
Prolia Denosumab 60 mg/mL Prefilled Syringe Injection by Amgen (RX) **Requires Refrigeration**
Original price $ 3,695.95Current price $ 2,450.00🔒 Medical License Required
Breast cancer medicines are designed to treat and manage various forms and stages of breast cancer by targeting cancerous cells and inhibiting their growth. These medicines can work through multiple mechanisms, such as hormone therapy to block hormones that fuel cancer growth, chemotherapy to kill rapidly dividing cells, targeted therapy to block specific proteins or genes involved in cancer progression, and immunotherapy to boost the body's natural defenses against cancer. They aim to reduce tumor size, prevent cancer spread, and improve survival rates.